A Three-dimensional Matrix System Containing Melatonin and Neural Stem Cells Repairs Damage from Traumatic Brain Injury in Rats

Overview

Journal Neural Regen Res

Date 2022 May 10

PMID 35535904

Authors

Xuan-Yu Fang

Da-Wei Zhao

Chao Zhang

Hong-Fei Ge

Xu-Yang Zhang

Feng-Chun Zhao

Yi-Bin Jiang

Hua Feng

Rong Hu

Affiliations

Soon will be listed here.

Abstract

Brain lesions can cause neural stem cells to activate, proliferate, differentiate, and migrate to the injured area. However, after traumatic brain injury, brain tissue defects and microenvironment changes greatly affect the survival and growth of neural stem cells; the resulting reduction in the number of neural stem cells impedes effective repair of the injured area. Melatonin can promote the survival, proliferation, and differentiation of neural stem cells under adverse conditions such as oxidative stress or hypoxia that can occur after traumatic brain injury. Therefore, we investigated the therapeutic effects of melatonin combined with neural stem cells on traumatic brain injury in rats. First, in vitro studies confirmed that melatonin promoted the survival of neural stem cells deprived of oxygen and glucose. Then, we established a three-dimensional Matrigel-based transplantation system containing melatonin and neural stem cells and then used it to treat traumatic brain injury in rats. We found that treatment with the Matrigel system containing melatonin and neural stem cells decreased brain lesion volume, increased the number of surviving neurons, and improved recovery of neurological function compared with treatment with Matrigel alone, neural stem cells alone, Matrigel and neural stem cells combined, and Matrigel and melatonin combined. Our findings suggest that the three-dimensional Matrigel-based transplantation system containing melatonin and neural stem cells is a potential treatment for traumatic brain injury.

Citing Articles

Tetrahydrofolate Attenuates Cognitive Impairment after Hemorrhagic Stroke by Promoting Hippocampal Neurogenesis via PTEN Signaling.

Zhang X, Zhang Q, Zhang Q, Wang H, Yin Y, Li H eNeuro. 2024; 11(6).

PMID: 38729764 PMC: 11149488. DOI: 10.1523/ENEURO.0021-24.2024.

Genetic pathways in cerebral palsy: a review of the implications for precision diagnosis and understanding disease mechanisms.

Xu Y, Li Y, Richard S, Sun Y, Zhu C Neural Regen Res. 2023; 19(7):1499-1508.

PMID: 38051892 PMC: 10883492. DOI: 10.4103/1673-5374.385855.

Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders.

Potes Y, Cachan-Vega C, Antuna E, Garcia-Gonzalez C, Menendez-Coto N, Boga J Int J Mol Sci. 2023; 24(5).

PMID: 36902233 PMC: 10002978. DOI: 10.3390/ijms24054803.

The Multiple Functions of Melatonin: Applications in the Military Setting.

Gancitano G, Reiter R Biomedicines. 2023; 11(1).

PMID: 36672513 PMC: 9855431. DOI: 10.3390/biomedicines11010005.

References

Zibara K, Ballout N, Mondello S, Karnib N, Ramadan N, Omais S . Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury. Neuropharmacology. 2018; 145(Pt B):177-198. DOI: 10.1016/j.neuropharm.2018.09.032. View

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J, Pujol S . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9):1323-41. PMC: 3466397. DOI: 10.1016/j.mri.2012.05.001. View

Shi W, Nie D, Jin G, Chen W, Xia L, Wu X . BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials. 2012; 33(11):3119-26. DOI: 10.1016/j.biomaterials.2012.01.009. View

Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao L . Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. Cell Transplant. 2017; 26(7):1118-1130. PMC: 5657730. DOI: 10.1177/0963689717714102. View

Gupta V, You Y, Li J, Klistorner A, Graham S . Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J Mol Neurosci. 2012; 49(1):96-104. DOI: 10.1007/s12031-012-9899-x. View

Zhang S, Chen S, Li Y, Liu Y . Melatonin as a promising agent of regulating stem cell biology and its application in disease therapy. Pharmacol Res. 2017; 117:252-260. DOI: 10.1016/j.phrs.2016.12.035. View

Chen Y, Zhao Q, Sun Y, Jin Y, Zhang J, Wu J . Melatonin induces anti-inflammatory effects via endoplasmic reticulum stress in RAW264.7 macrophages. Mol Med Rep. 2018; 17(4):6122-6129. DOI: 10.3892/mmr.2018.8613. View

Bitner B, Marcano D, Berlin J, Fabian R, Cherian L, Culver J . Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. ACS Nano. 2012; 6(9):8007-14. PMC: 3458163. DOI: 10.1021/nn302615f. View

Singhal A, Morris V, Labhasetwar V, Ghorpade A . Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 2013; 4:e903. PMC: 3847304. DOI: 10.1038/cddis.2013.362. View

10.

Faden A, Loane D . Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?. Neurotherapeutics. 2014; 12(1):143-50. PMC: 4322076. DOI: 10.1007/s13311-014-0319-5. View

11.

Smith C, Gentleman S, Leclercq P, Murray L, Griffin W, Graham D . The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol. 2012; 39(6):654-66. PMC: 3833642. DOI: 10.1111/nan.12008. View

12.

Gazalah H, Mantash S, Ramadan N, Al Lafi S, El Sitt S, Darwish H . Postnatal Neural Stem Cells in Treating Traumatic Brain Injury. Methods Mol Biol. 2016; 1462:689-710. DOI: 10.1007/978-1-4939-3816-2_38. View

13.

Ahmed S . The culture of neural stem cells. J Cell Biochem. 2008; 106(1):1-6. DOI: 10.1002/jcb.21972. View

14.

Barros D, Conde-Sousa E, Goncalves A, Han W, Garcia A, Amaral I . Engineering hydrogels with affinity-bound laminin as 3D neural stem cell culture systems. Biomater Sci. 2019; 7(12):5338-5349. PMC: 6864240. DOI: 10.1039/c9bm00348g. View

15.

Xu W, Lu X, Zheng J, Li T, Gao L, Lenahan C . Melatonin Protects Against Neuronal Apoptosis via Suppression of the ATF6/CHOP Pathway in a Rat Model of Intracerebral Hemorrhage. Front Neurosci. 2018; 12:638. PMC: 6156428. DOI: 10.3389/fnins.2018.00638. View

16.

Kong X, Li X, Cai Z, Yang N, Liu Y, Shu J . Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell Mol Neurobiol. 2007; 28(4):569-79. PMC: 11515016. DOI: 10.1007/s10571-007-9212-7. View

17.

Green A, Shuaib A . Therapeutic strategies for the treatment of stroke. Drug Discov Today. 2006; 11(15-16):681-93. DOI: 10.1016/j.drudis.2006.06.001. View

18.

Wilems T, Vardhan S, Wu S, Sakiyama-Elbert S . The influence of microenvironment and extracellular matrix molecules in driving neural stem cell fate within biomaterials. Brain Res Bull. 2019; 148:25-33. PMC: 6492525. DOI: 10.1016/j.brainresbull.2019.03.004. View

19.

Pavlovic D, Pekic S, Stojanovic M, Popovic V . Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae. Pituitary. 2019; 22(3):270-282. DOI: 10.1007/s11102-019-00957-9. View

20.

Ahmed A, Gajavelli S, Spurlock M, Chieng L, Bullock M . Stem cells for therapy in TBI. J R Army Med Corps. 2015; 162(2):98-102. DOI: 10.1136/jramc-2015-000475. View